Immuron Limited
IMRN
$1.92
$0.10855.99%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 82.60% | 111.54% | 164.32% | 178.50% | 204.67% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 82.60% | 111.54% | 164.32% | 178.50% | 204.67% |
| Cost of Revenue | 215.64% | 401.52% | 2,293.94% | 1,195.77% | 524.86% |
| Gross Profit | 51.74% | 65.81% | 86.47% | 117.25% | 172.37% |
| SG&A Expenses | 39.79% | 33.36% | 24.64% | 22.59% | 21.54% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 22.83% | 0.48% | -21.93% | -29.74% | -29.86% |
| Total Operating Expenses | 73.71% | 82.80% | 92.20% | 75.09% | 63.05% |
| Operating Income | -64.81% | -60.63% | -53.96% | -29.53% | -11.25% |
| Income Before Tax | -88.13% | -84.67% | -78.76% | -53.50% | -24.01% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -88.13% | -84.67% | -78.76% | -53.50% | -24.01% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -88.13% | -84.67% | -78.76% | -53.50% | -24.01% |
| EBIT | -64.81% | -60.63% | -53.96% | -29.53% | -11.25% |
| EBITDA | -65.21% | -60.99% | -54.26% | -29.94% | -11.25% |
| EPS Basic | -85.09% | -82.30% | -76.99% | -53.92% | -23.91% |
| Normalized Basic EPS | -98.39% | -96.72% | -90.16% | -45.90% | -6.90% |
| EPS Diluted | -86.84% | -83.19% | -76.99% | -53.92% | -23.91% |
| Normalized Diluted EPS | -98.39% | -96.72% | -90.16% | -45.90% | -6.90% |
| Average Basic Shares Outstanding | 0.19% | 0.11% | 0.03% | 0.01% | 0.00% |
| Average Diluted Shares Outstanding | 0.19% | 0.11% | 0.03% | 0.01% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |